Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Choosing Wisely: Evaluating Latent Factor Models in the Presence of a Contaminated Instrumental Variable with Varying Strength 0 0 1 1 0 0 24 24
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 1 2 48 1 5 14 94
Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California 0 1 4 14 1 4 12 24
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies 0 0 1 5 0 0 2 15
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 0 0 0 47 2 4 4 178
Estimating Lifetime or Episode-of-illness Costs 0 0 0 108 1 2 3 287
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 0 1 2 155
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 39 1 2 9 192
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 18 1 2 3 100
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 46 0 0 2 161
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 290 0 0 0 872
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 1 16 0 0 2 22
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 0 0 86 1 2 7 158
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 0 0 0 37
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 0 0 62 1 5 6 99
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 0 0 50 0 1 1 35
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 0 1 2 51
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 0 0 1 229
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 0 73 0 1 6 106
The Role of Physician Altruism in the Physician-Industry Relationship: Evidence from Linking Experimental and Observational Data 0 0 11 11 0 0 16 16
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 0 0 1 101
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 1 2 6 164
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 0 21 0 0 0 50
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 1 54 0 1 2 219
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 0 1 3 484 2 4 10 1,346
Use of propensity scores in non-linear response models: The case for health care expenditures 0 1 1 147 3 4 10 525
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 1 1 1 56
Total Working Papers 0 4 25 1,872 16 42 146 5,316


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 3 1 1 1 25
Comparing alternative models: log vs Cox proportional hazard? 0 0 2 148 0 1 5 572
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 3 3 5 318
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 1 3 7 46
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 3 4 7 249
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 1 2 2 48
Estimating lifetime or episode‐of‐illness costs under censoring 0 0 1 21 1 3 6 84
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 0 1 145 1 1 5 421
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 0 143 1 1 2 359
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 0 1 1 25
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 0 1 105 1 1 4 289
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 0 72 2 5 6 190
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 0 0 0 14
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 0 0 2 39 1 1 7 153
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 0 0 1 102
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 0 0 0 47
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 0 0 0 18
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 0 0 52 0 0 0 217
The impact of comparative effectiveness research on health and health care spending 0 0 0 35 1 1 2 276
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 1 4 9 928 9 22 43 2,731
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 1 2 2 36
Total Journal Articles 1 4 16 1,769 27 52 106 6,220


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 4 28 0 2 21 244
Total Software Items 0 0 4 28 0 2 21 244


Statistics updated 2025-11-08